Harpago

Over 70% of small-molecule therapeutics emerging from today's discovery pipelines are too poorly water-soluble to enable adequate bioavailability after oral intake. This solubility problem greatly hinders drug development and ultimately prevents patients from accessing potentially life-saving treatm... Read more